Evidence map›Paper›PMID 34988733›Full record

ArticleBioprocess and biosystems engineering2022

Green synthesis of silver nanoparticles using Rhodiola imbricata and Withania somnifera root extract and their potential catalytic, antioxidant, cytotoxic and growth-promoting activities.

Sahil Kapoor, Hemant Sood, Shweta Saxena, Om Prakash Chaurasia

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Biological Effect of Green Synthesis of Silver Nanoparticles Derived fromInternational journal of molecular sciences · 2025
    Article
  4. The EPMA journal · 2024
    Review
  5. Article
  6. Antifungal Activity ofJournal of functional biomaterials · 2023
    Article
  7. Antibiotics (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Pharmaceutics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sahil KapoorDefence Institute of High-Altitude Research (DRDO), C/O 56 APO, Leh-Ladakh, Jammu & Kashmir, 901205, India.
Hemant SoodDepartment of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, 173215, India. hemant.sood@juit.ac.in.ORCID http://orcid.org/0000-0001-5529-7727
Shweta SaxenaDefence Institute of High-Altitude Research (DRDO), C/O 56 APO, Leh-Ladakh, Jammu & Kashmir, 901205, India.
Om Prakash ChaurasiaDefence Institute of High-Altitude Research (DRDO), C/O 56 APO, Leh-Ladakh, Jammu & Kashmir, 901205, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents the development of a sustainable production process of environmentally benign silver nanoparticles (AgNPs) from aqueous root extract of Rhodiola imbricata (RI) and Withania somnifera (WS) for mitigating environmental pollution and investigating their potential applications in agriculture and biomedical industry. RIWS-AgNPs were characterized using several analytical techniques (UV-Vis, DLS, HR-TEM, SAED, EDX and FTIR). The antioxidant and anticancer activity of RIWS-AgNPs were estimated by DPPH and MTT assay, respectively. UV-Vis and DLS analysis indicated that equal ratio of RIWS-extract and silver nitrate (1:1) is optimum for green synthesis of well-dispersed AgNPs (λ

Indexed as

Antineoplastic AgentsMetal NanoparticlesRhodiolaWithaniaAntioxidantsChlorophyll AGreen Chemistry TechnologyPlant ExtractsSilverAntineoplastic AgentsAntioxidantsChlorophyll APlant ExtractsSilverAntioxidant activityGreen synthesisRhodiola imbricataSilver nanoparticlesWithania somnifera

Identifiers

PMID34988733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.